A 2026 scoping review of 105 AI-acne studies found the field focuses almost entirely on diagnosing acne from images. That image focus creates equity concerns for app users because dermatology AI performs worse on darker skin tones.
A scoping review maps every published study in an area, here acne AI. For people with acne, the question is whether phone-app results work across skin tones. The review context plus skin-tone testing suggests caution.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the 2026 review covered
- Why phone apps lean on photos
- Do results hold for darker skin?
- How to use an acne app more safely
What the 2026 review covered
The review by Frederickson, Gui, Barbieri and Daneshjou appeared in the International Journal of Dermatology in March 2026. The PubMed listing describes the PubMed, Cochrane and Scopus search with 105 included articles the PubMed record.
Of the 105 articles, 96.2% covered diagnosis only, 9.5% management only, and 5.7% both. The International Journal of Dermatology analysis reports that diagnosis-heavy mix the Wiley review page. App-relevant work therefore centers on image diagnosis, not treatment planning.
Why phone apps lean on photos
Most research trains models to label acne or severity from a picture. That task fits a phone camera and quick triage flow. It does not replace treatment choice, follow-up, or prescription decisions.
A JAMA Dermatology review of 41 dermatology apps found only 12% had peer-reviewed supporting evidence. None had FDA approval and only 5% had EU CE marking, the European conformity mark. Buyers see polished interfaces without matching validation behind them.
Do results hold for darker skin?
No, performance drops with darker skin in independent testing. The Stanford Diverse Dermatology Images test found ROC-AUC, a measure of diagnostic accuracy, fell 29-40% versus original results, with dark tones driving the drop the Science Advances study. Training data helps explain the gap. Published datasets underrepresent non-White and Fitzpatrick IV-VI skin, the darkest categories on a dermatology color scale.
Educational materials show only about 1 in 10 images in the Black-Brown range. A large Northwestern experiment adds clinical context. Specialists reached 38% accuracy and primary-care physicians 19% without AI, AI pairing raised accuracy, but skin-color disparities persisted. The gap was largest for clinicians who saw mostly White patients.
How to use an acne app more safely
No consumer app claiming to diagnose skin conditions has FDA approval, according to American Academy of Dermatology guidance the Academy statement via Newswise. There is therefore no guarantee of accuracy or safety from approval alone.
Treat app output as unvalidated triage, not diagnosis, and seek dermatologist review. This matters most for patients with darker skin. JAMA Dermatology reviewers give the same triage warning through AJMC coverage.
- Use the app only for tracking or early triage, not a final label
- Save clear photos, symptoms, duration, and products used for the visit
- Ask the clinician whether the tool was tested on your skin-tone range
- Check FDA and CE status plus diverse-skin validation before relying on results
You Might Also Like
- Skin-Tone Equity Gaps in 2026 Acne AI Research: Why Clinician Review Still Matters for People Using Acne Apps
- The 2026 Global Delphi Consensus on Acne and the Microbiome: Product-Claim Questions for People With Acne-Prone Skin
- Skin Microbiome Outcomes in the 2026 Probiotic Acne Review: Product-Claim Questions for People With Acne-Prone Skin